Statistical considerations when using a composite endpoint for comparing treatment groups (Q94829)
From MaRDI portal
!
This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use the normal view instead:
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Statistical considerations when using a composite endpoint for comparing treatment groups |
scientific article |
Statements
32
0 references
5
0 references
719-738
0 references
1 August 2012
0 references
Stephen W. Lagakos
0 references
